Stroke in Patients with Left Ventricular Assist Devices

Area of Science:

• Cardiology
• Neurology
• Medical Devices

Background:

• Left ventricular assist devices (LVADs) are crucial for end-stage heart failure patients, improving survival and quality of life.
• LVADs function as artificial pumps supporting circulation, but pose risks of thrombosis and bleeding.
• Increasing LVAD use necessitates familiarity with associated neurological complications for stroke neurologists.

Purpose of the Study:

• To highlight the increased risk of stroke in patients with LVADs.
• To inform neurologists about the unique challenges in managing stroke in this population.
• To emphasize the need for specialized knowledge in assessment and therapy for LVAD patients experiencing cerebrovascular events.

Main Methods:

• Review of reported stroke rates in LVAD patients.
• Analysis of risk factors for ischemic and hemorrhagic strokes.
• Discussion of current therapeutic limitations and considerations for reperfusion therapy.

Main Results:

• LVAD-associated stroke rates range from 10-30% at 2 years, significantly higher than controls.
• Ischemic and hemorrhagic strokes occur at nearly equal rates, peaking in the first year post-implantation.
• Treatment and patient-related factors contribute to stroke risk; reperfusion therapy evidence is limited.

Conclusions:

• LVAD implantation is associated with a substantially elevated risk of stroke.
• Understanding patient and treatment factors is key to managing stroke risk in LVAD patients.
• Neurologists require specialized knowledge to effectively manage cerebrovascular issues in this growing patient cohort.